Cargando…

Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer

Gene expression signatures have been used to predict the outcome of chemotherapy for breast cancer. The nucleosome footprint of cell-free DNA (cfDNA) carries gene expression information of the original tissues and thus may be used to predict the response to chemotherapy. Here we carried out the nucl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xu, Cai, Geng-Xi, Han, Bo-Wei, Guo, Zhi-Wei, Wu, Ying-Song, Lyu, Xiaoming, Huang, Li-Min, Zhang, Yuan-Bin, Li, Xin, Ye, Guo-Lin, Yang, Xue-Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997954/ https://www.ncbi.nlm.nih.gov/pubmed/33772032 http://dx.doi.org/10.1038/s41523-021-00237-5

Ejemplares similares

Integrative analyses of maternal plasma cell-free DNA nucleosome footprint differences reveal chromosomal aneuploidy fetuses gene expression profile
por: Zhang, Min, et al.
Publicado: (2022)

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer
por: Vanderstichele, Adriaan, et al.
Publicado: (2022)

Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer
por: CUI, HAI-BIN, et al.
Publicado: (2014)

Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
por: Trejo-Becerril, Catalina, et al.
Publicado: (2005)

Plasma-Derived Extracellular Vesicles Circular RNAs Serve as Biomarkers for Breast Cancer Diagnosis
por: Lin, Li, et al.
Publicado: (2021)

Conserved Substitution Patterns around Nucleosome Footprints in Eukaryotes and Archaea Derive from Frequent Nucleosome Repositioning through Evolution
por: Warnecke, Tobias, et al.
Publicado: (2013)

Hydroxyl-radical footprinting combined with molecular modeling identifies unique features of DNA conformation and nucleosome positioning
por: Shaytan, Alexey K., et al.
Publicado: (2017)

Changes of T2 Relaxation Time From Neoadjuvant Chemotherapy in Breast Cancer Lesions
por: Liu, Li, et al.
Publicado: (2016)

Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study
por: Sheng, Xue-Qing, et al.
Publicado: (2022)

Neoadjuvant sintilimab combined with chemotherapy in resectable locally advanced non-small cell lung cancer: case series and literature review
por: Yin, Cunli, et al.
Publicado: (2023)

Rapid and inexpensive preparation of genome-wide nucleosome footprints from model and non-model organisms
por: McKnight, Laura E., et al.
Publicado: (2021)

Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA
por: Cheng, Jordan, et al.
Publicado: (2022)

Statistical investigation of position-specific deformation pattern of nucleosome DNA based on multiple conformational properties
por: Yang, Xi, et al.
Publicado: (2011)

Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis
por: Zhang, Xi, et al.
Publicado: (2021)

Prognostic role of high neutrophil-to-lymphocyte ratio in breast cancer patients receiving neoadjuvant chemotherapy: Meta-analysis
por: Xue, Ling Bo, et al.
Publicado: (2019)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

A Deep-Learning Pipeline for TSS Coverage Imputation From Shallow Cell-Free DNA Sequencing
por: Han, Bo-Wei, et al.
Publicado: (2021)

Constitutive Nucleosome Depletion and Ordered Factor Assembly at the GRP78 Promoter Revealed by Single Molecule Footprinting
por: Gal-Yam, Einav Nili, et al.
Publicado: (2006)

Noninvasive prediction of axillary lymph node status in breast cancer using promoter profiling of circulating cell-free DNA
por: Guo, Zhi-Wei, et al.
Publicado: (2022)

Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial
por: Yang, Bo, et al.
Publicado: (2022)

Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level
por: Fatemi, Mehrnaz, et al.
Publicado: (2005)

Neoadjuvant immunotherapy combined with chemotherapy significantly improved patients’ overall survival when compared with neoadjuvant chemotherapy in non-small cell lung cancer: A cohort study
por: Dai, Fuqiang, et al.
Publicado: (2022)

In the human sperm nucleus, nucleosomes form spatially restricted domains consistent with programmed nucleosome positioning
por: Zhang, Mei-Zi, et al.
Publicado: (2019)

DANPOS: Dynamic analysis of nucleosome position and occupancy by sequencing
por: Chen, Kaifu, et al.
Publicado: (2013)

Noninvasive prediction of response to cancer therapy using promoter profiling of circulating cell‐free DNA
por: Guo, Zhi‐Wei, et al.
Publicado: (2020)

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
por: Huang, Yujing, et al.
Publicado: (2021)

Effect of Neoadjuvant Chemotherapy on the Serum Levels of Bone Turnover Markers in Women with Early-Stage Breast Cancer
por: Chen, YangYang, et al.
Publicado: (2015)

Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC
por: Zhou, Peng-zhe, et al.
Publicado: (2021)

Plasma Nucleosomes in Primary Breast Cancer
por: Mego, Michal, et al.
Publicado: (2020)

SELER: a database of super-enhancer-associated lncRNA- directed transcriptional regulation in human cancers
por: Guo, Zhi-Wei, et al.
Publicado: (2019)

The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: A systematic review and meta-analysis
por: Li, Xuan, et al.
Publicado: (2018)

Plasma cell-free DNA integrity: a potential biomarker to monitor the response of breast cancer to neoadjuvant chemotherapy
por: Wang, Wei, et al.
Publicado: (2019)

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
por: Zhu, Dexiang, et al.
Publicado: (2014)

Nucleosome positioning based on DNA sequence embedding and deep learning
por: Han, Guo-Sheng, et al.
Publicado: (2022)

Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer
por: Li, Zheng-Yan, et al.
Publicado: (2020)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
por: Wu, Jin, et al.
Publicado: (2022)

Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin
por: Wang, Ruo-Xi, et al.
Publicado: (2016)

Pretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma
por: Zhang, Guo-Yi, et al.
Publicado: (2015)

The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2016)

DNA methylation footprints during soybean domestication and improvement
por: Shen, Yanting, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k0lhparul5584djrbc056glujb